BioNTech currently produces 8 million doses of its vaccine every three to seven days at the new Marburg facility that the company purchased from Novartis last fall.

This 11-min. time-lapse shows the final step of production: technicians at BioNTech’s Marburg complex filter the vaccine before pumping it into bulk packages ready for shipping to a filling and ...

BioNTech SE said Friday that the European Medicines Agency (EMA) has approved its Marburg facility in Germany for the manufacture of the COVID-19 vaccine drug substance, which would boost annual ...

MAINZ, GERMANY, February 10, 2021 (GLOBE NEWSWIRE) - We started the manufacturing process at the Marburg facility with the execution of the first ...

German Chancellor Olaf Scholz is visiting the new manufacturing facility in Marburg today together with BioNTech co-founders Prof. Ugur Sahin, M.D., Chief Executive Officer, and Prof. Özlem ...

BioNTech will invest 40 million euros ... [1/2] A view of BioNTech building in Marburg, Germany, February 2, 2023. REUTERS/Fabian Bimmer Purchase Licensing Rights, opens new tab.

Chancellor Olaf Scholz of Germany and the BioNTech founders Ugur Sahin and Özlem Türeci view a model of plasmid at the BioNTech plant in Marburg, Germany, in February.

Moderna alleges Pfizer and BioNTech copied technology in their COVID-19 vaccine that Moderna ... A laboratory worker simulates the workflow in a BioNTech COVID-19 production room in Marburg, ...

Plasmids are an important starting material for the manufacturing of mRNA- and cell-based drugsThe new plasmid manufacturing facility aims to increase BioNTech’s autonomy and flexibility in ...

MAINZ, Germany, February 2, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced construction completion of the Company’s first proprietary plasmid DNA ...

MAINZ, Germany, February 2, 2023 – biontech se (Nasdaq: BNTX,“BioNTech” or“the Company”) today announced construction completion of the Company's first proprietary plasmid DNA ...